Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 20
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Culture-Free Sequencing of Mycobacterium Tuberculosis for Diagnosis and Genetic Diversity Identification

  • Mariner Llicer, Carla
[ES] La detección y diagnóstico de resistencias en Mycobacterium tuberculosis (MTB) supone un reto para el control de la tuberculosis (TB). La técnica diagnóstica implica el cultivo de muestras diagnósticas, pero este proceso es lento y retrasa los resultados hasta meses demorando la prescripción del tratamiento óptimo. El cultivo también se utiliza para enriquecer muestras diagnósticas con fines de investigación, como la secuenciación del genoma de MTB. Sin embargo, se desconoce si cultivar reduce la diversidad genética de la muestra diagnóstica, sesgando los resultados. Actualmente, las técnicas moleculares permiten evitar el cultivo en el diagnóstico, detectando resistencia a antibióticos más rápidamente, pero se limitan a identificar las mutaciones comunes asociadas a la resistencia a la rifampicina (RIF) e isoniazida (INH), los fármacos de primera línea. No obstante, la composición compleja de las muestras diagnósticas como el esputo sigue siendo un desafío para la secuenciación. Esta tesis presenta técnicas y estrategias de secuenciación para recuperar MTB a partir de esputos, centrándose en la diversidad genética en esputos y cultivos y explorando el potencial de la secuenciación para determinar resistencias. En el Capítulo 1 comparamos la diversidad genética entre pares de esputos y cultivos en dos entornos diferentes. Desarrollamos una técnica de secuenciación de esputos, realizando una secuenciación directa o enriquecida según la cantidad de MTB presente. Además, implementamos un flujo de análisis para descartar artefactos del procesamiento de muestras. Los resultados muestran una alta concordancia en la diversidad entre esputos y cultivos, cuestionando la hipótesis inicial del cuello de botella en el cultivo. En el Capítulo 2 exploramos las limitaciones del Gene Xpert MTB/RIF Ultra (XpertUltra) para identificar mutaciones de resistencia a RIF, examinando las mutaciones de resistencia más prevalentes en el sur de Mozambique. Utilizamos la secuenciación del genoma completo para identificar variantes de resistencia en cepas recolectadas en Manhiça, Mozambique. Detectamos dos cepas con mutaciones de resistencia a RIF no identificadas por el XpertUltra y una alta prevalencia de cepas resistentes a INH sin resistencia a RIF (no multirresistentes, MDR). Los resultados sugieren que el XpertUltra podría no detectar algunos casos de resistencia a RIF y/o INH, destacando la necesidad de incluir nuevas mutaciones en las pruebas moleculares. En el Capítulo 3 evaluamos el potencial de la secuenciación de amplicones para predecir la resistencia a antibióticos e identificar el linaje de las cepas. Diseñamos un panel de nueve genes asociados a la resistencia a siete antibióticos y dos regiones filogenéticas, poniendo a punto una PCR multiplex para amplificar todas las regiones en una sola reacción. A diferencia de otros paneles, los cebadores diseñados cubren los genes completos para detectar todas las mutaciones presentes. La secuenciación se realiza con MinION (Nanopore), una plataforma portátil con análisis en tiempo real. Comparamos las variantes obtenidas con las de Illumina para calibrar los parámetros del llamado de variantes y evitar falsos positivos. Los resultados muestran una alta correlación entre MinION e Illumina en la detección de resistencia e identificación de linajes, independientemente del tipo de muestra. Estos resultados, junto con el análisis en tiempo real de MinION, son prometedores para su implementación en atención primaria. En conclusión, esta tesis contribuye a los avances en la genómica de muestras diagnósticas. Por un lado, demostrando que el cultivo refleja la diversidad genética del esputo, y por otro, revelando el potencial de la secuenciación del genoma y de amplicones para predecir resistencia a antibióticos. Las técnicas y resultados que se presentan contribuirán a promover la secuenciación directa de esputo como técnica de diagnóstico rápida y precisa, pero también su uso para la investigación., [CA] La detecció i diagnòstic de resistències en Mycobacterium tuberculosis (MTB) suposa un repte per al control de la tuberculosi (TB). La tècnica de referència ha estat el cultiu de mostres diagnòstiques, però aquest procés és lent, retardant els resultats durant setmanes o mesos i dificultant la prescripció d'un tractament òptim. El cultiu també s'ha utilitzat per enriquir mostres diagnòstiques amb finalitats de recerca, com la seqüenciació del genoma de MTB. No obstant això, encara es desconeix si el cultiu redueix la diversitat genètica de la mostra diagnòstica, cosa que podria generar un biaix en els resultats. Actualment, les tècniques moleculars han permès evitar el cultiu en el diagnòstic, detectant resistència a antibiòtics més ràpidament, però es limiten a identificar les mutacions comunes associades a resistència a la rifampicina (RIF) i isoniazida (INH), els fàrmacs de primera línia. Tanmateix, la composició complexa de les mostres diagnòstiques com l'esput segueix sent un repte per a la seqüenciació. Aquesta tesi presenta tècniques i estratègies de seqüenciació per recuperar MTB a partir d'esputs, centrant-se en la diversitat genètica en esputs i cultius i explorant el potencial de la seqüenciació per determinar resistències. Al Capítol 1 comparem la diversitat genètica entre parelles d'esputs i cultius en dos entorns diferents. Desenvolupem una tècnica de seqüenciació d'esputs, realitzant una seqüenciació directa o enriquida segons la quantitat de MTB present. A més, implementem un flux d'anàlisi per descartar artefactes del processament de mostres. Els resultats mostren una alta concordança en la diversitat entre esputs i cultius, qüestionant la hipòtesi inicial d'un coll de botella al cultiu. Al Capítol 2 explorem les limitacions de la prova molecular Gene Xpert MTB/RIF Ultra (XpertUltra) per identificar mutacions de resistència a RIF, examinant les mutacions de resistència més prevalents al sud de Moçambic. Utilitzem la seqüenciació del genoma complet per identificar variants de resistència a antibiòtics en soques recol·lectades a Manhiça, Moçambic. Detectem dues soques amb mutacions de resistència a rifampicina no identificades per l'XpertUltra i una alta prevalença de soques resistents a INH sense resistència a RIF (no multiressistents, MDR). Els resultats sugereixen que l'XpertUltra pot no detectar alguns casos de resistència a RIF i/o INH, destacant la necessitat d'incloure noves mutacions en proves moleculars. Al Capítol 3 avaluem el potencial de la seqüenciació d'amplicons per predir resistència a antibiòtics i identificar el llinatge de les soques. Dissenyem un panell de nou gens associats a resistència a set antibiòtics i dues regions filogenètiques, posant a punt una PCR multiplex per amplificar totes les regions en una sola reacció. A diferència d'altres panells, els encebadors dissenyats cobreixen els gens complets, per detectar totes les mutacions presents. La seqüenciació es realitza amb MinION (Nanopore), una plataforma portàtil amb anàlisi en temps real. Comparem les variants obtingudes amb les d'Illumina per calibrar paràmetres per cridar de variants i evitar falsos positius. Els resultats mostren una alta correlació entre MinION i Illumina en la detecció de resistència i identificació de llinatges, independentment del tipus de mostra. Aquests resultats, juntament amb l'anàlisi en temps real de MinION, són prometedors per a la seva implementació en atenció primària. En conclusió, aquesta tesi contribueix als avanços en la genòmica directa de mostra diagnòstica. D'una banda, demostrant que el cultiu reflecteix la diversitat genètica de l'esput i, d'altra banda, revelant el potencial de la seqüenciació del genoma i d'amplicons per predir resistència a antibiòtics. Els resultats obtinguts superen les limitacions de les proves moleculars actuals, i les tècniques presentades podrien promoure la seqüenciació directa d'esput com a eina de diagnòstic ràpida i precisa, així com per a la investigació., [EN] Mycobacterium tuberculosis (MTB) detection and diagnosis of drug resistance(DR) have been a challenge for tuberculosis(TB) control. Culturing mycobacteria from diagnostic samples has been the most commonly used diagnostic technique. However, culturing depends on MTB's slow growth, delaying results and the prescription of optimal treatment for weeks to months. Culture is also essential for research purposes such as MTB genomics. However, it remains unclear whether it causes a bottleneck in the sample's original genetic diversity, potentially biasing results. Skipping the culturing step has been possible with the introduction of molecular techniques in surveillance systems. These reduce turnaround time and allow MTB and DR detection through a single assay. However, such tests are limited to detecting common mutations associated with rifampicin(RIF) and isoniazid(INH) resistance. Moreover, the complex composition of diagnostic samples, like sputum, continues to challenge sequencing workflows in research. In this thesis, we explore different sequencing approaches to recover and sequence MTB from sputum samples, focusing on overcoming the hypothesized culture bottleneck and evaluating the potential of sequencing for DR prediction. In Chapter 1, we compare genetic diversity within sputum-culture paired samples in two settings. We implement a culture-free sequencing (cfWGS) approach for sputum, using both direct and enriched sequencing, depending on the initial amount of MTB DNA. We also develop an analysis pipeline to filter artifactual variants from cfWGS approaches. To generalize results, three additional datasets are reanalyzed. The results show high concordance in genetic diversity between sputum-culture pairs, both in terms of presence and frequency of variants. These results contradict the initial culture bottleneck assumption, emphasizing the importance of tailored filtering steps depending on sample complexity. In Chapter 2, we explore the limitations of the Gene Xpert MTB/RIF Ultra (XpertUltra) for detecting non-common mutations and screen for prevalent DR mutations in southern Mozambique. We use WGS to identify DR variants in strains collected in Manhiça (Mozambique) during two time periods. Two strains were found to harbor RIF resistance mutations beyond XpertUltra's detection scope. We also detect a high prevalence of INH-resistant strains without RIF resistance (non-MDR TB). This suggests that XpertUltra, the primary diagnostic tool in the region, sometimes misclassifies RIF-resistant cases, highlighting the need for expanded drug and mutation coverage in molecular diagnostic tests. In Chapter 3, we assess the potential of targeted sequencing for DR prediction and lineage identification by designing a gene panel of 9 genes associated with resistance to 7 drugs and two phylogenetic regions. We develop a multiplex PCR to amplify all target regions in one reaction. Unlike other commercial panels, our primers cover entire genes allowing the identification of all mutations, not just those in hotspot regions. We employ the portable MinION (Nanopore) platform, which provides real-time analysis. A key aim is to calibrate parameters for MinION variant calling by comparing its results to Illumina sequencing, establishing a frequency cut-off to avoid false positives due to MinION's error rate. Our results show high concordance between MinION and Illumina in detecting DR and genotyping, regardless of the sample type. These findings present a significant advantage for future implementation in point-of-care systems. This thesis advances the field of cfWGS by confirming that culture mirrors sputum's genetic diversity and demonstrating the potential of whole genome and targeted sequencing to overcome the limitations of current molecular diagnostic tests in predicting DR. The techniques and findings presented could help promote cfWGS as a front-line approach for faster, more accurate diagnosis, and contribute to further research., This work has been supported by the following: European Research Council (ERC): H2020-ERC-COG/0800; Ministerio Español de Ciencia e Innovación: PID2022-137607OB-I00; Fundació La Caixa: HR21-00415, International Science and Technology Center (ISTC): Project #G-2143 and National Institute of Allergy and Infectious Diseases (NIH). This work was also supported by STOP TB partnership [STBP/TBREACH/GSA/W5-30: CA-3-D000920001], the TB Portals programme of the National Institutes of Health, the European Research Council [101001038-TB-RECONNECT: H2020-ERC-COG/0800 and 638553-TB-ACCELERATE], Generalitat Valenciana [AICO/2018/113], the Spanish Ministry of Science and Innovation [PID2019-104477RB-I00] and the Ministerio de Economía, Indústria y Competividad (SAF2016-77346-R)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Spatial and temporal distribution of SARS-CoV-2 diversity circulating in wastewater.

  • Pérez-Cataluña, Alba
  • Chiner-Oms, Álvaro
  • Cuevas-Ferrando, Enric
  • Díaz-Reolid, Azahara
  • Falcó, Irene
  • Randazzo, Walter
  • Girón-Guzmán, Inés
  • Allende, Ana
  • Bracho, María A.
  • Comas, Iñaki
  • Sánchez, Gloria
[EN] Wastewater-based epidemiology (WBE) has proven to be an effective tool for epidemiological surveillance of SARS-CoV-2 during the current COVID-19 pandemic. Furthermore, combining WBE together with highthroughput sequencing techniques can be useful for the analysis of SARS-CoV-2 viral diversity present in a given sample. The present study focuses on the genomic analysis of SARS-CoV-2 in 76 sewage samples collected during the three epidemiological waves that occurred in Spain from 14 wastewater treatment plants distributed throughout the country. The results obtained demonstrate that the metagenomic analysis of SARS-CoV-2 in wastewater allows the detection of mutations that define the B.1.1.7 lineage and the ability of the technique to anticipate the detection of certain mutations before they are detected in clinical samples. The study proves the usefulness of sewage sequencing to track Variants of Concern that can complement clinical testing to help in decision-making and in the analysis of the evolution of the pandemic., This study was supported by projects "VIRIDIANA" (AGL2017-82909/AEI/FEDER, UE) and MCEC-WATER (PID2020-116789RB-C42/AEI/FEDER, UE) funded by Spanish Ministry of Science, Innovation and Universities; CSIC (202070E101), Generalitat Valenciana (Covid_19-SCI), the European Union Next Generation EU (SGL2103034), the COVID-19 wastewater surveillance project (VATar COVID19), funded by the Spanish Ministry for the Ecological Transition and the Demographic Challenge and the Spanish Ministry of Health, the Instituto de Salud Carlos III (Ref COV20/00140), ERC TB-RECONNECT 101001038 funded by The European Union Next Generation EU and the Lagoon project (PROMETEO/2021/044). EC-F is recipient of a predoctoral contract from the MICINN, Call 2018 and AP-C was supported by a postdoctoral fellowship (APOSTD/21/292). We acknowledge NILSA, FACSA, and MITECO for authorizing the sampling. The authors thank Agustin Garrido Fern ' andez, and Andrea Lopez de Mota for their technical support.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco Marín, Clara
  • Wieczór, Miłosz
  • Mata, Carlos P.
  • Krieger, James
  • Ruiz Rodriguez, Paula
  • López Redondo, Maria Luisa
  • Francés Gómez, Clara
  • Melero, Roberto
  • Sánchez Sorzano, Carlos Óscar
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada Nadal, Alicia
  • Zamora Caballero, Sara
  • Gozalbo Rovira, Roberto
  • Sanz Frasquet, Carla
  • Arranz, Rocío
  • Bravo, Jeronimo
  • Rubio, Vicente
  • Marina, Alberto
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscolla, Mireia
  • Orozco López, Modesto
  • Llácer, José Luis
  • Carazo, Jose Maria
  • The IBV Covid19 Pipeline
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has since reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • García de Viedma, Darío
  • Ruiz-Rodríguez, Paula
  • Bracho, María Alma
  • Cancino-Muñoz, Irving
  • D'Auria, Giuseppe
  • Marco, Griselda de
  • García-González, Neris
  • Goig, Galo A.
  • Gómez-Navarro, Inmaculada
  • Jiménez-Serrano, Santiago
  • Martínez-Priego, Llucia
  • Ruiz-Hueso, Paula
  • Ruiz-Roldán, Lidia
  • Torres-Puente, Manuela
  • Alberola, Juan
  • Albert, Eliseo
  • Aranzamendi Zaldumbide, Maitane
  • Bea-Escudero, María Pilar
  • Boga, José Antonio
  • Bordoy, Antoni E.
  • Canut, Andrés
  • Carvajal, Ana
  • Cilla Eguiluz, Gustavo
  • Cordón Rodríguez, María Luz
  • Costa-Alcalde, José J.
  • Toro, María de
  • Toro Peinado, Inmaculada de
  • Pozo, José Luis del
  • Duchêne, Sebastián
  • Fernández-Pinero, Jovita
  • Fuster Escrivá, Begoña
  • Gimeno-Cardona, Concepción
  • González Galán, Verónica
  • Gonzalo Jimeno, Nieves
  • Hernáez Crespo, Silvia
  • Herranz, Marta
  • Lepe, José A.
  • López-Causapé, Carla
  • López-Hontangas, José Luis
  • Martín, Vicente
  • Martró, Elisa
  • Milagro Beamonte, Ana
  • Montes Ros, Milagrosa
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro-Marí, José María
  • Not, Anna
  • Oliver, Antonio
  • Palop-Borrás, Begoña
  • Parra Grande, Mónica
  • Pedrosa-Corral, Irene
  • Pérez González, María Carmen
  • Pérez-Lago, Laura
  • Pérez-Ruiz, Mercedes
  • Piñeiro Vázquez, Luis
  • Rabella, Nuria
  • Rezusta, Antonio
  • Robles Fonseca, Lorena
  • Rodríguez-Villodres, Ángel
  • Sanbonmatsu-Gámez, Sara
  • Sicilia, Jon
  • Soriano, Álex
  • Balaguer, María Dolores
  • Torres, Ignacio
  • Tristancho, Alexander
  • Marimón, José María
  • Seqcovid-Spain Consortium
  • Coscollá, Mireia
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Sanmartín, Isabel
  • González Recio, Oscar
SeqCOVID-Spain consortium: Álvaro Chiner-Oms, Irving Cancino-Muñoz, Mariana G. López, Manuela Torres-Puente, Inmaculada Gómez-Navarro, Santiago Jiménez-Serrano, Jordi Pérez-Tur, Darío García de Viedma, Laura Pérez-Lago, Marta Herranz, Jon Sicilia, Pilar Catalán-Alonso, Julia Suárez González, Patricia Muñoz, Mireia Coscolla, Paula Ruiz-Rodríguez, Fernando González-Candelas, Iñaki Comas, Lidia Ruiz-Roldán, María Alma Bracho, Neris García-González, Llúcia Martínez Priego, Inmaculada Galán-Vendrell, Paula Ruiz-Hueso, Griselda De Marco, María Loreto Ferrús-Abad, Sandra Carbó-Ramírez, Giuseppe D’Auria, Galo Adrian Goig, Juan Alberola, Jose Miguel Nogueira, Juan José Camarena, David Navarro, Eliseo Albert, Ignacio Torres, Maitane Aranzamendi Zaldumbide, Óscar Martínez Expósito, Nerea Antona Urieta, María de Toro, María Pilar Bea-Escudero, Jose Antonio Boga, Cristian Castelló-Abietar, Susana Rojo-Alba, Marta Elena Álvarez-Argüelles, Santiago Melón, Elisa Martró, Antoni E. Bordoy, Anna Not, Adrián Antuori, Anabel Fernández-Navarro, Andrés Canut-Blasco, Silvia Hernáez Crespo, Maria Luz Cordón Rodríguez, Maria Concepción Lecaroz Agara, Carmen Gómez-González, Amaia Aguirre-Quiñonero, José Israel López-Mirones, Marina Fernández-Torres, Maria Rosario Almela-Ferrer, Ana Carvajal, Juan Miguel Fregeneda-Grandes, Héctor Argüello, Gustavo Cilla Eguiluz, Milagrosa Montes Ros, Luis Piñeiro Vázquez, Ane Sorarrain, José María Marimón, José J. Costa-Alcalde, Rocío Trastoy, Gema Barbeito Castiñeiras, Amparo Coira, María Luisa Pérez del Molino, Antonio Aguilera, Begoña Palop-Borrás, Inmaculada de Toro Peinado, Maria Concepción Mediavilla Gradolph, Mercedes Pérez-Ruiz, Mirian Fernández-Alonso, Jose Luis del Pozo, Oscar González-Recio, Mónica Gutiérrez-Rivas, Jovita Fernández-Pinero, Miguel Ángel Jiménez Clavero, Begoña Fuster Escrivá, Concepción Gimeno Cardona, María Dolores Ocete Mochón, Rafael Medina-Gonzalez, José Antonio Lepe, Verónica González Galán, Ángel Rodríguez-Villodres, Nieves Gonzalo Jiménez, Jordi Reina, Carla López-Causapé, Maria Dolores Gómez-Ruiz, Eva M. Gonzalez-Barbera, José Luis López-Hontangas, Vicente Martín, Antonio J. Molina, Tania Fernandez-Villa, Ana Milagro Beamonte, Nieves Felisa Martínez-Cameo, Yolanda Gracia-Grataloup, Rosario Moreno-Muñoz, Maria Dolores Tirado Balaguer, José María Navarro-Marí, Irene Pedrosa-Corral, Sara Sanbonmatsu-Gámez, Antonio Oliver, Mónica Parra Grande, Bárbara Gómez Alonso, Francisco José Arjona Zaragozí, Maria Carmen Pérez González, Francisco Javier Chamizo López, Ana Bordes-Benítez, Núria Rabella, Ferran Navarro, Elisenda Miró, Antonio Rezusta, Alexander Tristancho, Encarnación Simarro Córdoba, Julia Lozano-Serra, Lorena Robles Fonseca, Álex Soriano, Francisco Javier Roig Sena, Hermelinda Vanaclocha Luna, Isabel Sanmartín, Daniel García-Souto, Ana Pequeño-Valtierra, Jose M. C. Tubio, Javier Temes, Jorge Rodríguez-Castro, Martín Santamarina García, Manuel Rodríguez-Iglesias, Fátima Galán-Sanchez, Salud Rodríguez-Pallares, José Manuel Azcona-Gutiérrez, Miriam Blasco-Alberdi, Alfredo Mayor, Alberto L. García-Basteiro, Gemma Moncunill, Carlota Dobaño, Pau Cisteró, Oriol Mitjà, Camila González-Beiras, Martí Vall-Mayans, Marc Corbacho-Monné, Andrea Alemany, Cristina Muñoz-Cuevas, Guadalupe Rodríguez-Rodríguez, Rafael Benito, Sonia Algarate, Jessica Bueno, Andrea Vergara-Gómez, Miguel J. Martínez, Jordi Vila, Elisa Rubio, Aida Peiró-Mestres, Jessica Navero-Castillejos, David Posada, Diana Valverde, Nuria Estévez, Iria Fernández-Silva, Loretta de Chiara, Pilar Gallego-García, Nair Varela, Ulises Gómez-Pinedo, Mónica Gozalo-Margüello, Maria Eliecer Cano García, José Manuel Méndez-Legaza, Jesus Rodríguez-Lozano, María Siller, Daniel Pablo-Marcos, Maria Montserrat Ruiz-García, Antonio Galiana, Judith Sánchez-Almendro, Maria Isabel Gascón Ros, Cristina Juana Torregrosa-Hetland, Eva María Pastor Boix, Paloma Cascales Ramos, Pedro Luis Garcinuño Enríquez, Salvador Raga Borja, Julia González Cantó, Olalla Martínez Macias, Adolfo de Salazar, Laura Viñuela González, Natalia Chueca, Federico García, Cristina Gómez-Camarasa, Amparo Farga Martí, Rocío Falcón, Victoria Domínguez-Márquez, Anna M. Planas, Israel Fernández-Cádenas, Maria Ángeles Marcos, Carmen Ezpeleta, Ana Navascués, Ana Miqueleiz Zapatero, Manuel Segovia, Antonio Moreno-Docón, Esther Viedma, Raúl Recio Martínez, Irene Muñoz-Gallego, Sara Gonzalez-Bodi, Maria Dolores Folgueira, Jesús Mingorance, Elias Dahdouh, Fernando Lázaro-Perona, María Rodríguez-Tejedor, María Pilar Romero-Gómez, Julio García-Rodríguez, Juan Carlos Galán, Mario Rodríguez-Dominguez, Laura Martínez-García, Melanie Abreu Di Berardino, Manuel Ponce-Alonso, Jose Maria González-Alba, Ivan Sanz-Muñoz, Diana Pérez San José, Maria Gil Fortuño, Juan B. Bellido-Blasco, Alberto Yagüe Muñoz, Noelia Hernández Pérez, Helena Buj Jordá, Óscar Pérez Olaso, Alejandro González Praetorius, Nora Mariela Martínez Ramírez, Aida Ramírez Marinero, Eduardo Padilla León, Alba Vilas Basil, Mireia Canal Aranda, Albert Bernet Sánchez, Alba Bellés Bellés, Eric López González, Iván Prats Sánchez, Mercè García-González, Miguel José Martínez-Lirola, Manuel Ángel Rodríguez Maresca, Maria Teresa Cabezas Fernández, María Eugenia Carrillo Gil, Maria Paz Ventero Martín, Carmen Molina Pardines, Nieves Orta Mira, María Navarro Cots, Inmaculada Vidal Catalá, Isabel García Nava, Soledad Illescas Fernández-Bermejo, José Martínez-Alarcón, Marta Torres-Narbona, Cristina Colmenarejo, Lidia García-Agudo, Jorge A. Pérez García, Martín Yago López, María Ángeles Goberna Bravo, Victoria Simón García, Gonzalo Llop Furquet, Agustín Iranzo Tatay, Sandra Moreno-Marro, Noelia Lozano Rodríguez, Amparo Broseta Tamarit, Juan José Badiola Díez, Amparo Martínez-Ramírez, Ana Dopazo, Sergio Callejas, Alberto Benguría, Begoña Aguado, Antonio Alcamí, Marta Bermejo Bermejo, Ricardo Ramos-Ruíz, Víctor Manuel Fernández Soria, Fernando Simón Soria & Mercedes Roig Cardells, The coronavirus disease 2019 (COVID-19) pandemic has affected the world radically since 2020. Spain was one of the European countries with the highest incidence during the first wave. As a part of a consortium to monitor and study the evolution of the epidemic, we sequenced 2,170 samples, diagnosed mostly before lockdown measures. Here, we identified at least 500 introductions from multiple international sources and documented the early rise of two dominant Spanish epidemic clades (SECs), probably amplified by superspreading events. Both SECs were related closely to the initial Asian variants of SARS-CoV-2 and spread widely across Spain. We inferred a substantial reduction in the effective reproductive number of both SECs due to public-health interventions (Re < 1), also reflected in the replacement of SECs by a new variant over the summer of 2020. In summary, we reveal a notable difference in the initial genetic makeup of SARS-CoV-2 in Spain compared with other European countries and show evidence to support the effectiveness of lockdown measures in controlling virus spread, even for the most successful genetic variants., This work was mainly funded by the Instituto de Salud Carlos III project COV20/00140, with additional funding by Spanish National Research Council project CSIC-COV19-021, Ministerio de Ciencia project PID2019-104477RB-100, ERC StG 638553 and ERC CoG 101001038 to I.C., and BFU2017-89594R to F.G.C. M.C. is supported by Ramón y Cajal program from Ministerio de Ciencia and grants RTI2018-094399-A-I00 and Generalitat Valenciana (Regional Government) project SEJI/2019/011. We gratefully acknowledge Hospital Universitari Vall d’Hebron, Instituto de Salud Carlos III, IrsiCaixa AIDS Research Lab and all the international researchers and institutions that submitted sequenced SARS-CoV-2 genomes to the GISAID’s EpiCov Database (Supplementary Table 1), as an important part of our analyses has been made possible by the sharing of their work. We also thank Unidad de Bioinformática y Estadística, Centro de Investigación Príncipe Felipe, for allowing us to use the Computer Cluster to perform some of the bioinformatic analysis., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco-Marín, Clara
  • Wieczor, Milosz
  • Mata, Carlos P.
  • Krieger, James
  • López-Redondo, Marisa
  • Francés-Gómez, Clara
  • Ruiz-Rodríguez, Paula
  • Melero, Roberto
  • Sorzano, Carlos Óscar S.
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada-Nadal, Alicia
  • Zamora-Caballero, Sara
  • Gozalbo-Rovira, Roberto
  • Sanz-Frasquet, Carla
  • Bravo, Jerónimo
  • Rubio, Vicente
  • Marina, Alberto
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscollá, Mireia
  • Orozco, Modesto
  • Llácer, José Luis
  • Carazo, José M.
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has now reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness., This research work was supported by the European Commission–NextGenerationEU through the CSIC Global Health Platform. Additionally, authors would like to acknowledge economic support from the Spanish Ministry of Science and Innovation through Grants: PID2019-104757RB-I00 funded by MCIN/AEI/ 10.13039/501100011033, RTI2018-094399-A-I00, and “ERDF A way of making Europe”, by the “European Union”, Grant SEV 2017-0712 funded by MCIN/AEI /10.13039/501100011033, the “Comunidad Autónoma de Madrid" through Grant: S2017/BMD3817, and the European Union (EU) and Horizon 2020 through grants: Marie-Curie Fellowship EnLaCES (MSCA IF 2020, Proposal: 101024130) (to JK), HighResCells (ERC - 2018 - SyG, Proposal: 810057), and iNEXT-Discovery (Proposal: 871037). AM, VR, JB and JLL are funded by CIBERER-ISCIII (proposal: COV20/00437), Fondo Supera COVID-19 (proposal: CSICCOVID19-082), Banco Santander (Proposal: BlockAce), and CSIC PTI Salud Global (Proposal: 202080E110). VR is funded by the Spanish Ministry of Science and Innovation through Grant PID2020-120322RB-C21. IC is funded by project PID2019-104477RB-100, Fondo COVID COV20/00140 and ERC CoG 101001038. MC is funded by the RyC program from the Spanish Ministry of Science and Innovation, the Generalitat Valenciana (SEJI/2019/011)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gene evolutionary trajectories in Mycobacterium tuberculosis reveal temporal signs of selection

  • Chiner-Oms, Álvaro
  • López, Mariana G.
  • Moreno-Molina, Miguel
  • Furió, Victoria
  • Comas, Iñaki
11 páginas, 4 figuras, 1 tabla y fórmulas. Plots of all trajectories calculated (Dataset S7) have been deposited in Figshare (https://dx.doi.org/10.6084/m9.figshare.19335854). Previously published data were also used for this work [data from Brites et al. (4), Coll et al. (29), Stucki et al. (30), Guerra-Assunc¸~ao et al. (31), Zignol et al. (32), Bos et al. (33), Ates et al. (34), Comas et al. (10, 35), Borrell et al. (36), and Cancino-Mu~noz et al. (37)]., SignificancePrevious attempts to identify the action of natural selection in the Mycobacterium tuberculosis complex (MTBC) were limited by sample size and averaging across time and lineages. We investigate changes in selective pressures across time for every single gene of the MTBC. We developed a methodology to analyze temporal signals of selection in a large dataset (∼5,000 complete genomes) and showed that 1) almost half of the genes seem to have been under positive selection at some point in time; 2) experimentally confirmed epitopes tend to accumulate more mutations in deeper branches than in external branches; and 3) temporal signals identify genes that were conserved in the past but under positive selection in the present, suggesting ongoing adaptation to the host., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program Grant 101001038 (TB-RECONNECT). In addition, this work was funded by Ministerio de Ciencia (Spanish Government) Project PID2019- 104477RB-I00 and Generalitat Valenciana Project AICO/2018/113. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

  • Antimycobacterial Susceptibility Testing Group
  • Georghiou, Sophia B.
  • Rodwell, Timothy C.
  • Korobitsyn, Alexei
  • Abbadi, Said H.
  • Ajbani, Kanchan
  • Alffenaar, Jan-Willem
  • Alland, David
  • Alvarez, Nataly
  • Andres, Sönke
  • Ardizzoni, Elisa
  • Aubry, Alexandra
  • Baldan, Rossella
  • Ballif, Marie
  • Barilar, Ivan
  • Böttger, Erik C.
  • Chakravorty, Soumitesh
  • Claxton, Pauline M.
  • Cirillo, Daniela M.
  • Comas, Iñaki
  • Coulter, Chris
  • Denkinger, Claudia M.
  • Derendinger, Brigitta
  • Desmond, Edward P.
  • Steenwinkel, Jurriaan E. M. de
  • Dheda, Keertan
  • Diacon, Andreas H.
  • Dolinger, David L.
  • Dooley, Kelly E.
  • Egger, Matthias
  • Ehsani, Soudeh
  • Farhat, Maha R.
  • Fattorini, Lanfranco
  • Finci, Iris
  • Fournier Le Ray, Laure
  • Furió, Victoria
  • Groenheit, Ramona
  • Gumbo, Tawanda
  • Heysell, Scott K.
  • Hillemann, Doris
  • Hoffmann, Harald
  • Hsueh, Po-Ren
  • Hu, Yi
  • Huang, Hairong
  • Hussain, Alamdar
  • Ismail, Farzana
  • Izumi, Kiyohiko
  • Jagielski, Tomasz
  • Johnson, John L.
  • Kambli, Priti
  • Kaniga, Koné
  • Karunaratne, G. H. R. Eranga
  • Sharma, Meenu Kaushal
  • Keller, Peter M.
  • Kelly, Ellis C.
  • Kholina, Margarita
  • Kohli, Mikashmi
  • Kranzer, Katharina
  • Laurenson, Ian F.
  • Limberis, Jason
  • Lin, S-Y. Grace
  • Liu, Yongge
  • López-Gavín, Alexandre
  • Lyander, Anna
  • Machado, Diana
  • Martínez Fernández, Elena
  • Masood, Faisal
  • Mitarai, Satoshi
  • Mvelase, Nomonde R.
  • Niemann, Stefan
  • Nikolayevskyy, Vladyslav
  • Maurer, Florian P.
  • Merker, Matthias
  • Miotto, Paolo
  • Omar, Shaheed V.
  • Otto-Knapp, Ralf
  • Palaci, Moisés
  • Palacios Gutiérrez, Juan José
  • Peacock, Sharon J.
  • Peloquin, Charles A.
  • Perera, Jennifer
  • Pierre-Audigier, Catherine
  • Pholwat, Suporn
  • Posey, James E.
  • Prammananan, Therdsak
  • Rigouts, Leen
  • Robledo, Jaime
  • Rockwood, Neesha
  • Rodrigues, Camilla
  • Salfinger, Max
  • Schechter, Marcos C.
  • Seifert, Marva
  • Sengstake, Sarah
  • Shinnick, Thomas
  • Shubladze, Natalia
  • Sintchenko, Vitali
  • Sirgel, Frederick
  • Somasundaram, Sulochana
  • Sterling, Timothy R.
  • Spitaleri, Andrea
  • Streicher, Elizabeth
  • Supply, Philip
  • Svensson, Erik
  • Tagliani, Elisa
  • Tahseen, Sabira
  • Takaki, Akiko
  • Theron, Grant
  • Torrea, Gabriela
  • Van Deun, Armand
  • van Ingen, Jakko
  • Van Rie, Annelies
  • van Soolingen, Dick
  • Vargas Jr, Roger
  • Venter, Amour
  • Veziris, Nicolas
  • Villellas, Cristina
  • Viveiros, Miguel
  • Warren, Robin
  • Wen, Shu'an
  • Werngren, Jim
  • Wilkinson, Robert J.
  • Yang, Caie
  • Yılmaz, F. Ferda
  • Zhang, Tingting
  • Zimenkov, Danila
  • Ismail, Nazir
  • Köser, Claudio U.
  • Schön, Thomas
11 páginas, 2 figuras, 1 tabla, Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance., I. Comas was supported by PID2019-104477RB-I00 from the Spanish Science Ministry and by ERC (CoG 101001038), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fine-grain population structure and transmission patterns of Mycobacterium tuberculosis in southern Mozambique, a high TB/HIV burden area

  • Saavedra Cervera, Belén
  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • García Marín, Ana María
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Villamayor, Luis
  • Madrazo-Moya, Carlos Francisco
  • Mambuque, Edson
  • Sequera, Guillermo Víctor
  • Respeito, Durval
  • Blanco, Silvia
  • Augusto, Orvalho
  • López-Varela, Elisa
  • Garcia-Basteiro, Alberto L.
  • Comas, Iñaki
14 paginas, 5 figuras, 2 tablas., Genomic studies of the Mycobacterium tuberculosis complex (MTBC) might shed light on the dynamics of its transmission, especially in high-burden settings, where recent outbreaks are embedded in the complex natural history of the disease. To this end, we conducted a 1 year prospective surveillance-based study in Mozambique. We applied whole-genome sequencing (WGS) to 295 positive cultures. We fully characterized MTBC isolates by phylogenetics and dating evaluation, and carried out a molecular epidemiology analysis to investigate further associations with pre-defined transmission risk factors. The majority of strains (49.5%, 136/275) belonged to lineage (L) 4; 57.8 % of them (159/275) were in genomic transmission clusters (cut-off 5 SNPs), and a strikingly high proportion (45.5%) shared an identical genotype (0 SNP pairwise distance). We found two 'likely endemic' clades, comprising 67 strains, belonging to L1.2, which dated back to the late 19th century and were associated with recent spread among people living with human immunodeficiency virus (PLHIV). We describe for the first time the population structure of MTBC in our region, a high tuberculosis (TB)/HIV burden area. Clustering analysis revealed an unforeseen pattern of spread and high rates of progression to active TB, suggesting weaknesses in TB control activities. The long-term presence of local strains in Mozambique, which were responsible for large transmission among HIV/TB-coinfected patients, calls into question the role of HIV in TB transmission., This project received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programmes 101001038 (TB-RECONNECT), PID2019-104477RB-I00 from Ministerio de Economía y Competitividad (Spanish Government) (to I.C.). We acknowledge support from the Spanish Ministry of Science, Innovation and Universities through the ‘Centro de Excelencia Severo Ochoa 2019–2023’.Programme (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Programme. B.S receives a pre-doctoral fellowship from the Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and co-funded by European Social Fund (AGAUR)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics

  • Cancino-Muñoz, Irving
  • López, Mariana G.
  • Torres-Puente, Manuela
  • Villamayor, Luis M.
  • Borras, Rafael
  • Borras-Manez, Maria
  • Bosque, Montserrat
  • Camarena, Juan J.
  • Colijn, Caroline
  • Colomer-Roig, Ester
  • Colomina, Javier
  • Escribano, Isabel
  • Esparcia-Rodriguez, Oscar
  • Garcia-Garcia, Francisco
  • Gil-Brusola, Ana
  • Gimeno, Concepción
  • Gimeno-Gascón, Adelina
  • Gomila-Sard, Barbara
  • Gonzales-Granda, Damiana
  • Gonzalo-Jiménez, Nieves
  • Guna-Serrano, María Remedio
  • López-Hontangas, José Luis
  • Martín-González, Coral
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro, María
  • Orta, Nieves
  • Pérez, Elvira
  • Prat, Josep
  • Rodríguez, Juan Carlos
  • Ruiz-García, María Montserrat
  • Vanaclocha, Hermelinda
  • Comas, Iñaki
23 páginas, 4 figuras, 1 tabla., Transmission is a driver of tuberculosis (TB) epidemics in high-burden regions, with assumed negligible impact in low-burden areas. However, we still lack a full characterization of transmission dynamics in settings with similar and different burdens. Genomic epidemiology can greatly help to quantify transmission, but the lack of whole genome sequencing population-based studies has hampered its application. Here, we generate a population-based dataset from Valencia region and compare it with available datasets from different TB-burden settings to reveal transmission dynamics heterogeneity and its public health implications. We sequenced the whole genome of 785 Mycobacterium tuberculosis strains and linked genomes to patient epidemiological data. We use a pairwise distance clustering approach and phylodynamic methods to characterize transmission events over the last 150 years, in different TB-burden regions. Our results underscore significant differences in transmission between low-burden TB settings, i.e., clustering in Valencia region is higher (47.4%) than in Oxfordshire (27%), and similar to a high-burden area as Malawi (49.8%). By modeling times of the transmission links, we observed that settings with high transmission rate are associated with decades of uninterrupted transmission, irrespective of burden. Together, our results reveal that burden and transmission are not necessarily linked due to the role of past epidemics in the ongoing TB incidence, and highlight the need for in-depth characterization of transmission dynamics and specifically tailored TB control strategies., European Research Council 638553-TB-ACCELERATE; European Research Council 101001038-TBRECONNECT; Ministerio de Ciencia e Innovación SAF2016-77346-R, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Epidemiological cluster identification using multiple data sources: an approach using logistic regression

  • Susvitasari, Kurnia
  • Tupper, Paul F.
  • Cancino-Muñoz, Irving
  • López, Mariana G.
  • Comas, Iñaki
  • Colijn, Caroline
In the management of infectious disease outbreaks, grouping cases into clusters and understanding their underlying epidemiology are fundamental tasks. In genomic epidemiology, clusters are typically identified either using pathogen sequences alone or with sequences in combination with epidemiological data such as location and time of collection. However, it may not be feasible to culture and sequence all pathogen isolates, so sequence data may not be available for all cases. This presents challenges for identifying clusters and understanding epidemiology, because these cases may be important for transmission. Demographic, clinical and location data are likely to be available for unsequenced cases, and comprise partial information about their clustering. Here, we use statistical modelling to assign unsequenced cases to clusters already identified by genomic methods, assuming that a more direct method of linking individuals, such as contact tracing, is not available. We build our model on pairwise similarity between cases to predict whether cases cluster together, in contrast to using individual case data to predict the cases' clusters. We then develop methods that allow us to determine whether a pair of unsequenced cases are likely to cluster together, to group them into their most probable clusters, to identify which are most likely to be members of a specific (known) cluster, and to estimate the true size of a known cluster given a set of unsequenced cases. We apply our method to tuberculosis data from Valencia, Spain. Among other applications, we find that clustering can be predicted successfully using spatial distance between cases and whether nationality is the same. We can identify the correct cluster for an unsequenced case, among 38 possible clusters, with an accuracy of approximately 35 %, higher than both direct multinomial regression (17 %) and random selection (< 5 %)., This project received funding from the Euroepan Research Council ERC TB-RECONNECT 101001038, Ministerio de Ciencia (Spanish Government) PID2019-104477RB-100 and by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Deciphering the Tangible Spatio-Temporal Spread of a 25-Year Tuberculosis Outbreak Boosted by Social Determinants

  • López, Mariana G.
  • Campos-Herrero, M. Isolina
  • Torres-Puente, Manuela
  • Canas, Fernando
  • Comin, Jessica
  • Copado, Rodolfo
  • Wintringer, Penelope
  • Iqbal, Zamin
  • Lagarejos, Eduardo
  • Moreno-Molina, Miguel
  • Pérez-Lago, Laura
  • Pino, Berta
  • Sante, Laura
  • García de Viedma, Darío
  • Samper, Sofia
  • Comas, Iñaki
15 páginas, 5 figuras, 1 tabla, Outbreak strains of Mycobacterium tuberculosis are promising candidates as targets in the search for intrinsic determinants of transmissibility, as they are responsible for many cases with sustained transmission; however, the use of low-resolution typing methods and restricted geographical investigations represent flaws in assessing the success of long-lived outbreak strains. We can now address the nature of outbreak strains by combining large genomic data sets and phylodynamic approaches. We retrospectively sequenced the whole genome of representative samples assigned to an outbreak circulating in the Canary Islands (the GC strain) since 1993, which accounts for ~20% of local tuberculosis cases. We selected a panel of specific single nucleotide polymorphism (SNP) markers for an in-silico search for additional outbreak-related sequences within publicly available tuberculosis genomic data. Using this information, we inferred the origin, spread, and epidemiological parameters of the GC strain. Our approach allowed us to accurately trace the historical and more recent dispersion of the GC strain. We provide evidence of a highly successful nature within the Canarian archipelago but limited expansion abroad. Estimation of epidemiological parameters from genomic data disagree with a distinctive biology of the GC strain. With the increasing availability of genomic data allowing for the accurate inference of strain spread and critical epidemiological parameters, we can now revisit the link between Mycobacterium tuberculosis genotypes and transmission, as is routinely carried out for SARS-CoV-2 variants of concern. We demonstrate that social determinants rather than intrinsically higher bacterial transmissibility better explain the success of the GC strain. Importantly, our approach can be used to trace and characterize strains of interest worldwide. IMPORTANCE Infectious disease outbreaks represent a significant problem for public health. Tracing outbreak expansion and understanding the main factors behind emergence and persistence remain critical to effective disease control. Our study allows researchers and public health authorities to use Whole-Genome Sequencing-based methods to trace outbreaks, and shows how available epidemiological information helps to evaluate the factors underpinning outbreak persistence. Taking advantage of all the freely available information placed in public repositories, researchers can accurately establish the expansion of an outbreak beyond original boundaries, and determine the potential risk of a strain to inform health authorities which, in turn, can define target strategies to mitigate expansion and persistence. Finally, we show the need to evaluate strain transmissibility in different geographic contexts to unequivocally associate spread to local or pathogenic factors, an important lesson taken from genomic surveillance of SARS-CoV-2., This project has been funded by the European Research Council (101001038-TBRECONNECT), the Ministerio de Economía, Industria y Competitividad (PID2019-104477RB-I00), and the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global) to I.C. This project has been funded by the Instituto de Salud Carlos III (FIS18/0336) and the Gobierno de Aragón/Fondo Social Europeo “Construyendo Europa desde Aragón” to SS, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study

  • Martínez-Martínez, Francisco José
  • Massinga, Arsenia J
  • Jesus, Áuria De
  • Ernesto, Rita M.
  • Cano-Jiménez, Pablo
  • Chiner-Oms, Álvaro
  • Gómez-Navarro, Inmaculada
  • Guillot-Fernández, Marina
  • Guinovart, Caterina
  • Sitoe, Antonio
  • Vubil, Delfino
  • Bila, Rubao
  • Gujamo, Rufino
  • Enosse, Sonia
  • Jiménez-Serrano, Santiago
  • Torres-Puente, Manuela
  • Comas, Iñaki
  • Mandomando, Inacio
  • López, Mariana G.
  • Mayor, Alfredo
9 hojas, 4 figuras, 1 tabla. Demographic data of the participants are available in the appendix (pp 40–42). Genome sequences are publicly available on GISAID. All scripts used for the analysis, and beta and delta subtree files are publicly available at https://gitlab.com/tbgenomicsunit/mozcovid. The study protocol (appendix pp 1–35) and clinical questionnaire (appendix pp 36–39) will be available with publication, Background: From the start of the SARS-CoV-2 outbreak, global sequencing efforts have generated an unprecedented amount of genomic data. Nonetheless, unequal sampling between high-income and low-income countries hinders the implementation of genomic surveillance systems at the global and local level. Filling the knowledge gaps of genomic information and understanding pandemic dynamics in low-income countries is essential for public health decision making and to prepare for future pandemics. In this context, we aimed to discover the timing and origin of SARS-CoV-2 variant introductions in Mozambique, taking advantage of pandemic-scale phylogenies. Methods: We did a retrospective, observational study in southern Mozambique. Patients from Manhiça presenting with respiratory symptoms were recruited, and those enrolled in clinical trials were excluded. Data were included from three sources: (1) a prospective hospital-based surveillance study (MozCOVID), recruiting patients living in Manhiça, attending the Manhiça district hospital, and fulfilling the criteria of suspected COVID-19 case according to WHO; (2) symptomatic and asymptomatic individuals with SARS-CoV-2 infection recruited by the National Surveillance system; and (3) sequences from SARS-CoV-2-infected Mozambican cases deposited on the Global Initiative on Sharing Avian Influenza Data database. Positive samples amenable for sequencing were analysed. We used Ultrafast Sample placement on Existing tRees to understand the dynamics of beta and delta waves, using available genomic data. This tool can reconstruct a phylogeny with millions of sequences by efficient sample placement in a tree. We reconstructed a phylogeny (~7·6 million sequences) adding new and publicly available beta and delta sequences. Findings: A total of 5793 patients were recruited between Nov 1, 2020, and Aug 31, 2021. During this time, 133 328 COVID-19 cases were reported in Mozambique. 280 good quality new SARS-CoV-2 sequences were obtained after the inclusion criteria were applied and an additional 652 beta (B.1.351) and delta (B.1.617.2) public sequences were included from Mozambique. We evaluated 373 beta and 559 delta sequences. We identified 187 beta introductions (including 295 sequences), divided in 42 transmission groups and 145 unique introductions, mostly from South Africa, between August, 2020 and July, 2021. For delta, we identified 220 introductions (including 494 sequences), with 49 transmission groups and 171 unique introductions, mostly from the UK, India, and South Africa, between April and November, 2021. Interpretation: The timing and origin of introductions suggests that movement restrictions effectively avoided introductions from non-African countries, but not from surrounding countries. Our results raise questions about the imbalance between the consequences of restrictions and health benefits. This new understanding of pandemic dynamics in Mozambique can be used to inform public health interventions to control the spread of new variants. Funding: European and Developing Countries Clinical Trials, European Research Council, Bill & Melinda Gates Foundation, and Agència de Gestió d'Ajuts Universitaris i de Recerca., This publication was produced by MozCovid which is part of the EDCTP2 programme supported by the EU (grant number RIA2020EF-3005-MozCOVID). The COVID-19 testing was supported by Emory Global Health Institute, University of Emory, through the CHAMPS Program funded by the Bill & Melinda Gates Foundation (under the grant OPP1126780 to Robert Breiman, subcontract SC00003286). This work was also supported by the European Research Council under the EU’s Horizon 2020 Research and Innovation Program grant (101001038; TB-RECONNECT), the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global), the Departament d’Universitats i Recerca de la Generalitat de Catalunya (AGAUR; 2021 SGR 01517), and the Ministerio de Ciencia e Innovación (Spanish Government) Project PID2019–104477RB-I00. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya (http://cerca.cat/en/suma/). We also acknowledge support from the Spanish Ministry of Science and Innovation and State Research Agency through the Centro de Excelencia Severo Ochoa 2019–2023 Program (CEX2018–000806-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Genomic approaches for tuberculosis management and control, Deploying sequencing advances to the clinic

  • Comas, Iñaki
  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • Farhat, Maha R.
  • Semuto Ngabonziza, Jean Claude
  • Campos, Josefina
  • Moreno-Molina, Miguel
18 páginas, 2 figuras., Research at IC laboratory is funded by European Research Council (TB-RECONNECT Program Grant 101001038), Ministerio de Ciencia (Spanish Government) Project PID2019-104477RB-I00, European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). JSN is funded by research project ‘Innovate to reduce rifampicin resistance tuberculosis in Rwanda and beyond’ with financial support from ITM’s SOFI programme supported by the Flemish Government, Science & Innovation. ACO is supported by a RyC grant RYC2021‐031461‐I funded by MCIN/AEI/ 10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

  • Álvarez-Herrera, Miguel
  • Sevilla, Jordi
  • Ruiz-Rodríguez, Paula
  • Vergara, Andrea
  • Vila, Jordi
  • Cano-Jiménez, Pablo
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Coscollá, Mireia
Viral mutations within patients nurture the adaptive potential of SARS-CoV-2 during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein we describe VIPERA (Viral Intra-Patient Evolution Reporting and Analysis), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. It has been validated using positive and negative control datasets and successfully applied to a novel case, contributing to easy and automatic analysis of intra-patient SARS-CoV-2 sequences., This work was funded by the Spanish Ministry of Science (CNS2022-135116) and the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the Global Health Platform (PTI+ Salud Global) of the Spanish National Research Council (CSIC). MAH and PRR are supported by the PTI+ Salud Global. JS is supported by the CSIC’s JAE intro programme. FGC was funded by project PID2021-127010OB-I00 from the Spanish Ministry of Science and CIPROM2021-053 from the Generalitat Valenciana. IC is funded by the European Research Council (101001038-TB640 RECONNECT) and the Spanish Ministry of Economy, Industry and Competitiveness (PID2019- 104477RB-I00). MC is funded by the Spanish Ministry of Science (PID2021-123443OB-I00)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Monitoring of first-line drug resistance mutations outside the scope of Xpert MTB/RIF Ultra is needed for successful control of DR-TB in Southern Mozambique

  • Mariner-Llicer, Carla
  • Saavedra Cervera, Belén
  • Mambuque, Edson
  • Gomes, Neide
  • Munguambe, Shilzia
  • Villamayor, Luis M.
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Nguenha, Dinis
  • Respeito, Durval
  • Tembe, Gustavo
  • López, Mariana G.
  • Comas, Iñaki
  • García-Basteiro, Alberto L.
Multidrug-resistant(MDR) tuberculosis in Southern Africa is of great concern, exacerbated by the spread of a clone harboring a mutation missed by Xpert Ultra. In Southern Mozambique, the presence of such mutation and rising cases of non-MDR isoniazid resistance highlights the need to ensure accurate detection of antimicrobial-resistance in the country., This work was supported by STOP TB partnership (STBP/TBREACH/GSA/W5-30: CA-3-D000920001 to AGB), the TB Portals program of the National Institutes of Health, the European Research Council (TB RECONNECT: H2020-ERC-COG/0800 to I. C.,), Generalitat Valenciana (AICO/2018/113 to I. C.) and the Spanish Ministry of Science and Innovation (PID2019-104477RB-I00 to I. C.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

  • Álvarez-Herrera, Miguel
  • Sevilla, Jordi
  • Ruiz-Rodríguez, Paula
  • Vergara, Andrea
  • Vila, Jordi
  • Cano-Jiménez, Pablo
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Coscollá, Mireia
15 páginas, 9 figuras, Viral mutations within patients nurture the adaptive potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein, we describe Viral Intra-Patient Evolution Reporting and Analysis (VIPERA), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, which revealed population dynamics and evidence of adaptive evolution. VIPERA is available under a free software license at https://github.com/PathoGenOmics-Lab/VIPERA., This work is a part of project CNS2022-135116 funded by MCIN/AEI/10.13039/501100011033, by the European Union Next GenerationEU/PRTR, and grant PID2021-123443OB-I00 funded by MICIN/AEI/10.13039/501100011033 and ERDF A way of making Europe. M.A.H. and P.R.R. are supported by the PTI+ Salud Global European Commission – NextGenerationEU (Regulation EU 2020/2094). J.S. is supported by the CSIC’s JAE intro program. F.G.C. was funded by project PID2021-127010OB-I00 from the Spanish Ministry of Science and CIPROM2021-053 from the Generalitat Valenciana. I.C. is funded by the European Research Council (101001038-TB-RECONNECT) and the Spanish Ministry of Economy, Industry and Competitiveness (PID2019-104477RB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis

  • García Marín, Ana María
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Villamayor, Luis M.
  • Borrás, Rafael
  • Borrás-Máñez, María
  • Bosque, Montserrat
  • Camarena, Juan J.
  • Colomer-Roig, Ester
  • Colomina, Javier
  • Escribano, Isabel
  • Esparcia-Rodríguez, Oscar
  • Gil-Brusola, Ana
  • Gimeno-Cardona, Concepción
  • Gimeno-Gascón, Adelina
  • Gomila-Sard, Bárbara
  • González-Granda, Damiana
  • Gonzalo-Jiménez, Nieves
  • Guna-Serrano, María del Remedio
  • López-Hontangas, José Luis
  • Martín-González, Coral
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro, María
  • Orta, Nieves
  • Pérez, Elvira
  • Prat, Josep
  • Rodríguez, Juan Carlos
  • Ruiz-García, María Montserrat
  • Vanaclocha, Hermelinda
  • González-Candelas, Fernando
  • Furió, Victoria
  • Valencia Region Tuberculosis Working Group
  • Comas, Iñaki
9 páginas, 2 figuras, 1 tabla, Background: In June, 2021, WHO published the most complete catalogue to date of resistance-conferring mutations in Mycobacterium tuberculosis. Here, we aimed to assess the performance of genome-based antimicrobial resistance prediction using the catalogue and its potential for improving diagnostics in a real low-burden setting. Methods: In this retrospective population-based genomic study M tuberculosis isolates were collected from 25 clinical laboratories in the low-burden setting of the Valencia Region, Spain. Culture-positive tuberculosis cases reported by regional public health authorities between Jan 1, 2014, and Dec 31, 2016, were included. The drug resistance profiles of these isolates were predicted by the genomic identification, via whole-genome sequencing (WGS), of the high-confidence resistance-causing variants included in the catalogue and compared with the phenotype. We determined the minimum inhibitory concentration (MIC) of the isolates with discordant resistance profiles using the resazurin microtitre assay. Findings: WGS was performed on 785 M tuberculosis complex culture-positive isolates, and the WGS resistance prediction sensitivities were: 85·4% (95% CI 70·8–94·4) for isoniazid, 73·3% (44·9–92·2) for rifampicin, 50·0% (21·1–78·9) for ethambutol, and 57·1% (34·0–78·2) for pyrazinamide; all specificities were more than 99·6%. Sensitivity values were lower than previously reported, but the overall pan-susceptibility accuracy was 96·4%. Genotypic analysis revealed that four phenotypically susceptible isolates carried mutations (rpoB Leu430Pro and rpoB Ile491Phe for rifampicin and fabG1 Leu203Leu for isoniazid) known to give borderline resistance in standard phenotypic tests. Additionally, we identified three putative resistance-associated mutations (inhA Ser94Ala, katG Leu48Pro, and katG Gly273Arg for isoniazid) in samples with substantially higher MICs than those of susceptible isolates. Combining both genomic and phenotypic data, in accordance with the WHO diagnostic guidelines, we could detect two new multidrug-resistant cases. Additionally, we detected 11 (1·6%) of 706 isolates to be monoresistant to fluoroquinolone, which had been previously undetected. Interpretation: We showed that the WHO catalogue enables the detection of resistant cases missed in phenotypic testing in a low-burden region, thus allowing for better patient-tailored treatment. We also identified mutations not included in the catalogue, relevant at the local level. Evidence from this study, together with future updates of the catalogue, will probably lead in the future to the partial replacement of culture testing with WGS-based drug susceptibility testing in our setting. Funding: European Research Council and the Spanish Ministerio de Ciencia., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program Grant 101001038 (TB-RECONNECT; awarded to IC), from Ministerio de Ciencia (Spanish Government) Project PID2019-104477RB-I00 (awarded to IC), and from Generalitat Valenciana Project AICO/2018/113 (awarded to IC). AMG-M is funded by a Formación deProfesorado Universitario grant programme (FPU19/04562) from Ministerio de Universidades (Spanish Government). IC is also supported by the European Commission–NextGenerationEU, through Centro Superior de Investigaciones Científicas Global Health Platform (PTI Salud Global). We thank all the members of the Valencia Region Tuberculosis Working Group., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic diversity within diagnostic sputum samples is mirrored in the culture of Mycobacterium tuberculosis across different settings

  • Mariner-Llicer, Carla
  • Goig, Galo A.
  • Torres-Puente, Manuela
  • Vashakidze, Sergo
  • Villamayor, Luis M.
  • Saavedra-Cervera, Belen
  • Mambuque, Edson
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Rosenthal, Alex
  • Gabrielian, Andrei
  • Shurgaia, Marika
  • Shubladze, Natalia
  • García-Basteiro, Alberto L.
  • López, Mariana G.
  • Comas, Iñaki
11 páginas, 6 figuras, Culturing and genomic sequencing of Mycobacterium tuberculosis (MTB) from tuberculosis (TB) cases is the basis for many research and clinical applications. The alternative, culture-free sequencing from diagnostic samples, is promising but poses challenges to obtain and analyse the MTB genome. Paradoxically, culture is assumed to impose a diversity bottleneck, which, if true, would entail unexplored consequences. To unravel this paradox we generate high-quality genomes of sputum-culture pairs from two different settings after developing a workflow for sequencing from sputum and a tailored bioinformatics analysis. Careful downstream comparisons reveal sources of sputum-culture incongruences due to false positive/negative variation associated with factors like low input MTB DNA or variable genomic depths. After accounting for these factors, contrary to the bottleneck dogma, we identify a 97% variant agreement within sputum-culture pairs, with a high correlation also in the variants' frequency (0.98). The combined analysis from five different settings and more than 100 available samples shows that our results can be extrapolated to different TB epidemic scenarios, demonstrating that for the cases tested culture accurately mirrors clinical samples., This work has been supported by the following: European Research Council (ERC): H2020-ERC-COG/0800; Ministerio Español de Ciencia e Innovación: PID2022-137607OB-I00 and Fundació La Caixa: HR21-00415 received by I.C; Stop TB partnership (TB REACH): STBP/ TBREACH/GSA/W5-30 received by A.G.B; and International Science and Technology Center (ISTC): Project #G-2143; National Institute of Allergy and Infectious Diseases (NIH) received by N.S. We would like to thank Katharine Walter for reviewing the manuscript and providing her feedback, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Complete genomes reveal a refined map of Mycobacterium tuberculosis genetic diversity across evolutionary scales

  • García-Marín, Ana María
  • Torres-Puente, Manuela
  • Martínez-Priego, Llucia
  • De Marco, Griselda
  • Moreno-Molina, Miguel
  • Hunt, Martin
  • Iqbal, Zamin
  • Gil-Brusola, Ana
  • López, Mariana G.
  • González-Candelas, Fernando
  • Alonso-Del-Real, Javier
  • Comas, Iñaki
20 páginas, 8 figuras, 1 tabla., Elucidating the evolution and epidemiology of Mycobacterium tuberculosis requires comprehensive characterization of its genomic diversity; however, short-read sequencing fails to resolve part of this variation. Here, we assembled 216 complete genomes from clinical isolates in the Valencia Region, Spain, using long-read sequencing. This dataset, mostly encompassing Lineage 4, provides a refined map of M. tuberculosis genetic diversity across evolutionary scales. Complete genomes uncover a median of 312 (-1 to 792) additional SNPs per pairwise comparison, revealing an estimated evolutionary rate 1.44-fold higher than that inferred from short-read mapping. This diversity is concentrated in discrete hotspots, particularly within the pe/ppe gene family, where gene conversion is a major driver of nucleotide diversity. While most PE/PPE epitopes remain highly conserved, suggesting strong purifying selection, some involved in vaccine candidates are affected by gene conversion, with unknown consequences. At the epidemiological scale, additional resolution is gained from SNPs previously masked and newly resolved indels and structural variation, refining genetic transmission networks. Finally, at the within-host level, the use of patient-specific reference genomes allows us to capture genuine diversity during infection, showing that previous approaches led to false positive calls. Together, these findings delineate the landscape of M. tuberculosis genomic diversity and provide a framework for more accurate inference of pathogen evolution, host-pathogen interactions, and transmission dynamics., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (Grant 101001038, TB-RECONNECT) awarded to I.C. Additional support was provided by the Spanish Ministry of Science and Innovation (PID2022-137607OB-I00) and the Generalitat Valenciana (Project CIPROM/2023/30), both also awarded to I.C., and PID2021-127919OB-I00 and PID2024-155977OB-I00 to FGC. AGM has been supported by a ‘Formación de Profesorado Universitario’ (FPU) grant (FPU19/ 04562) from the Spanish Ministry of Universities, and the Health Research 2021 Programme (TB-TARGET_HR21-00415) by LaCaixa Foundation. Work in IC’s laboratory is further supported by the European Union’s Next Generation, through CSIC’s Global Health Platform (PTI Salud Global). JAR is hired under the Generation D initiative, promoted by Red.es, an organisation attached to the Ministry for Digital Transformation and the Civil Service, for the attraction and retention of talent through grants and training contracts (MMT24-PTI-SG-01), financed by the Recovery, Transformation, and Resilience Plan through the European Union’s Next Generation funds., Peer reviewed, Sin experimentacion animal ni uso de NAMs
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation

  • Ginex, Tiziana
  • Marco Marín, Clara
  • Wieczór, Miłosz
  • Mata, Carlos P.
  • Krieger, James
  • Ruiz Rodriguez, Paula
  • López Redondo, Maria Luisa
  • Francés Gómez, Clara
  • Melero, Roberto
  • Sánchez Sorzano, Carlos Óscar
  • Martínez, Marta
  • Gougeard, Nadine
  • Forcada Nadal, Alicia
  • Zamora Caballero, Sara
  • Gozalbo Rovira, Roberto
  • Sanz Frasquet, Carla
  • Arranz, Rocío
  • Bravo, Jeronimo
  • Rubio, Vicente
  • Marina, Alberto
  • Geller, Ron
  • Comas, Iñaki
  • Gil, Carmen
  • Coscolla, Mireia
  • Orozco López, Modesto
  • Llácer, José Luis
  • Carazo, Jose Maria
  • The IBV Covid19 Pipeline
The S:A222V point mutation, within the G clade, was characteristic of the 20E (EU1) SARS-CoV-2 variant identified in Spain in early summer 2020. This mutation has since reappeared in the Delta subvariant AY.4.2, raising questions about its specific effect on viral infection. We report combined serological, functional, structural and computational studies characterizing the impact of this mutation. Our results reveal that S:A222V promotes an increased RBD opening and slightly increases ACE2 binding as compared to the parent S:D614G clade. Finally, S:A222V does not reduce sera neutralization capacity, suggesting it does not affect vaccine effectiveness.